Santen Pharmaceutical Co (JP:4536) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Santen Pharmaceutical Co. has announced the cancellation of 16,985,400 treasury shares, representing 4.7% of its outstanding shares, with the action set to be completed by November 29, 2024. This strategic move is expected to leave the company with 347,036,854 outstanding shares, streamlining its share structure.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.
